Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue Suppl 2
447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma
Free
Online download statistics by month:
Online download statistics by month: November 2021 to November 2024
Abstract
Full
Pdf
Nov 2021
322
0
21
Dec 2021
106
0
6
Jan 2022
46
0
6
Feb 2022
100
0
13
Mar 2022
210
0
7
Apr 2022
108
0
6
May 2022
88
0
12
Jun 2022
44
0
6
Jul 2022
18
0
3
Aug 2022
40
0
0
Sep 2022
42
0
12
Oct 2022
50
0
7
Nov 2022
38
0
4
Dec 2022
60
0
14
Jan 2023
30
0
4
Feb 2023
44
0
5
Mar 2023
18
0
2
Apr 2023
32
0
7
May 2023
36
0
1
Jun 2023
16
0
3
Jul 2023
34
0
10
Aug 2023
36
0
10
Sep 2023
56
0
10
Oct 2023
38
0
3
Nov 2023
36
0
4
Dec 2023
46
0
2
Jan 2024
26
0
0
Feb 2024
20
0
3
Mar 2024
20
0
3
Apr 2024
38
0
7
May 2024
48
0
5
Jun 2024
52
0
7
Jul 2024
32
0
3
Aug 2024
20
0
3
Sep 2024
52
0
17
Oct 2024
50
0
9
Nov 2024
18
0
3
Total
2070
0
238
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?